IDH-mutant astrocytomas are classified as CNS WHO grade 4 if a CDKN2A/B homozygous deletion is detected, irrespective of histological features such as necrosis or microvascular proliferation [17]. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).